Susquehanna International Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.9M | Sell |
131,700
-113,600
| -46% | -$19.9M | ﹤0.01% | 1940 |
|
|
2025
Q4 | $41.7M | Sell |
245,300
-87,500
| -26% | -$13.4M | ﹤0.01% | 1523 |
|
|
2025
Q3 | $43.9M | Buy |
332,800
+176,200
| +113% | +$21.1M | 0.01% | 1448 |
|
|
2025
Q2 | $16.6M | Buy |
156,600
+46,400
| +42% | +$5.04M | ﹤0.01% | 2203 |
|
|
2025
Q1 | $13.7M | Buy |
110,200
+57,400
| +109% | +$7.49M | ﹤0.01% | 2146 |
|
|
2024
Q4 | $6.5M | Sell |
52,800
-22,300
| -30% | -$2.63M | ﹤0.01% | 3211 |
|
|
2024
Q3 | $8.37M | Buy |
75,100
+13,000
| +21% | +$1.42M | ﹤0.01% | 2862 |
|
|
2024
Q2 | $6.63M | Buy |
62,100
+35,800
| +136% | +$3.94M | ﹤0.01% | 3011 |
|
|
2024
Q1 | $3.17M | Buy |
26,300
+3,500
| +15% | +$429K | ﹤0.01% | 4421 |
|
|
2023
Q4 | $2.8M | Sell |
22,800
-1,900
| -8% | -$237K | ﹤0.01% | 4688 |
|
|
2023
Q3 | $3.2M | Sell |
24,700
-6,600
| -21% | -$879K | ﹤0.01% | 4266 |
|
|
2023
Q2 | $3.88M | Sell |
31,300
-6,200
| -17% | -$834K | ﹤0.01% | 3940 |
|
|
2023
Q1 | $5.49M | Sell |
37,500
-42,800
| -53% | -$6.33M | ﹤0.01% | 3328 |
|
|
2022
Q4 | $12.8M | Sell |
80,300
-74,600
| -48% | -$10.9M | ﹤0.01% | 1966 |
|
|
2022
Q3 | $20.6M | Buy |
154,900
+99,700
| +181% | +$15.2M | 0.01% | 1400 |
|
|
2022
Q2 | $8.61M | Sell |
55,200
-26,600
| -33% | -$4.09M | ﹤0.01% | 2411 |
|
|
2022
Q1 | $12.7M | Sell |
81,800
-1,700
| -2% | -$247K | ﹤0.01% | 2234 |
|
|
2021
Q4 | $10.8M | Sell |
83,500
-62,300
| -43% | -$8.19M | ﹤0.01% | 2603 |
|
|
2021
Q3 | $19M | Sell |
145,800
-31,400
| -18% | -$4.74M | ﹤0.01% | 2027 |
|
|
2021
Q2 | $32.5M | Sell |
177,200
-163,000
| -48% | -$28.2M | ﹤0.01% | 1530 |
|
|
2021
Q1 | $55.9M | Buy |
340,200
+200,400
| +143% | +$33M | 0.01% | 1028 |
|
|
2020
Q4 | $23.1M | Sell |
139,800
-67,300
| -32% | -$10M | ﹤0.01% | 1587 |
|
|
2020
Q3 | $29.5M | Buy |
207,100
+125,400
| +153% | +$15.5M | 0.01% | 1183 |
|
|
2020
Q2 | $9.02M | Buy |
81,700
+20,900
| +34% | +$2.31M | ﹤0.01% | 2258 |
|
|
2020
Q1 | $6.06M | Buy |
60,800
+3,200
| +6% | +$414K | ﹤0.01% | 2330 |
|
|
2019
Q4 | $8.6M | Sell |
57,600
-12,300
| -18% | -$1.67M | ﹤0.01% | 2258 |
|
|
2019
Q3 | $8.96M | Buy |
69,900
+18,300
| +35% | +$2.45M | ﹤0.01% | 2102 |
|
|
2019
Q2 | $7.36M | Sell |
51,600
-6,700
| -11% | -$900K | ﹤0.01% | 2239 |
|
|
2019
Q1 | $8.33M | Buy |
58,300
+33,500
| +135% | +$4.37M | ﹤0.01% | 1917 |
|
|
2018
Q4 | $3.07M | Sell |
24,800
-21,300
| -46% | -$3.16M | ﹤0.01% | 2904 |
|
|
2018
Q3 | $7.75M | Sell |
46,100
-48,600
| -51% | -$8.36M | ﹤0.01% | 2181 |
|
|
2018
Q2 | $16.3M | Buy |
94,700
+1,900
| +2% | +$311K | 0.01% | 1462 |
|
|
2018
Q1 | $14M | Buy |
92,800
+10,300
| +12% | +$1.51M | 0.01% | 1507 |
|
|
2017
Q4 | $11.1M | Buy |
82,500
+19,800
| +32% | +$2.75M | ﹤0.01% | 1735 |
|
|
2017
Q3 | $9.17M | Sell |
62,700
-69,500
| -53% | -$10.5M | ﹤0.01% | 1849 |
|
|
2017
Q2 | $20.6M | Sell |
132,200
-30,400
| -19% | -$4.65M | 0.01% | 1154 |
|
|
2017
Q1 | $23.6M | Sell |
162,600
-25,100
| -13% | -$3.27M | 0.01% | 967 |
|
|
2016
Q4 | $20.5M | Buy |
187,700
+34,900
| +23% | +$3.89M | 0.01% | 1036 |
|
|
2016
Q3 | $18.6M | Sell |
152,800
-123,100
| -45% | -$16.6M | 0.01% | 1066 |
|
|
2016
Q2 | $39M | Buy |
275,900
+101,500
| +58% | +$15M | 0.02% | 611 |
|
|
2016
Q1 | $22.8M | Sell |
174,400
-61,800
| -26% | -$7.69M | 0.01% | 916 |
|
|
2015
Q4 | $33.2M | Buy |
236,200
+31,900
| +16% | +$4.42M | 0.02% | 814 |
|
|
2015
Q3 | $27.1M | Buy |
204,300
+40,700
| +25% | +$7.01M | 0.01% | 978 |
|
|
2015
Q2 | $28.8M | Sell |
163,600
-22,600
| -12% | -$4.06M | 0.01% | 1018 |
|
|
2015
Q1 | $32.2M | Sell |
186,200
-121,300
| -39% | -$20.8M | 0.01% | 883 |
|
|
2014
Q4 | $50.3M | Sell |
307,500
-75,500
| -20% | -$12.5M | 0.02% | 728 |
|
|
2014
Q3 | $61.5M | Buy |
383,000
+182,100
| +91% | +$28M | 0.02% | 634 |
|
|
2014
Q2 | $29.5M | Sell |
200,900
-100,400
| -33% | -$13.9M | 0.01% | 1064 |
|
|
2014
Q1 | $41.8M | Buy |
301,300
+143,600
| +91% | +$21.6M | 0.02% | 733 |
|
|
2013
Q4 | $20M | Buy |
157,700
+24,900
| +19% | +$2.58M | 0.01% | 1353 |
|
|
2013
Q3 | $12.2M | Buy |
132,800
+2,800
| +2% | +$226K | 0.01% | 1684 |
|
|
2013
Q2 | $8.93M | Buy |
+130,000
| New | +$7.95M | 0.01% | 1907 |
|
Other funds holding JAZZ
VPM
VCM
EC
Susquehanna International Group's JAZZ Position: Q1 2026 in Review
Susquehanna International Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q1 2026, selling an estimated $156K and leaving 5,914 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #7587.
Susquehanna International Group first reported a position in JAZZ in Q2 2013 and has held it in 47 quarters since. The position peaked at $30.8M in Q1 2014. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Susquehanna International Group held 5,914 shares of Jazz Pharmaceuticals worth $1.12M as of Q1 2026.
- Susquehanna International Group sold 893 Jazz Pharmaceuticals shares in Q1 2026, an estimated $156K.
- Jazz Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7587 holding.
- Susquehanna International Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
- Susquehanna International Group's Jazz Pharmaceuticals position peaked at $30.8M in Q1 2014.
- 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.